Melange Secondaries Partners II, LP has filed an amendment to its offering details, revealing a total offering amount of $724.4 million. This update is significant as it showcases the company's ongoing commitment to the private equity sector.
The filing, dated October 29, 2026, indicates that the company has successfully sold the entire offering amount, with no remaining funds available. This achievement reflects a strong interest from investors, as the company has reported a total of 126 investors already involved.
Background
Melange Secondaries Partners II, LP is a limited partnership based in Austin, Texas. The company operates under the jurisdiction of Delaware and focuses on pooled investment funds, specifically in the private equity fund space. The firm has been active in the market, with its most recent filings including a D/A on October 29, 2026, a D/A on July 7, 2026, and a D filing on June 11, 2026.
What the Filing Says
The recent filing states, "totalOfferingAmount: 724425000" and confirms that the total amount sold is equal to this figure, indicating a successful fundraising effort. The filing also notes that smaller investment amounts may be accepted at the discretion of the General Partner.
Impact
This development may affect the firm's stakeholders, including the 126 investors already involved, as well as potential future investors who may look to participate in similar offerings. The absence of non-accredited investors suggests that the company is targeting a specific, qualified investor base, which may influence its future fundraising strategies.
What's Next
The filing does not say what happens next.
Read Next
Workers United Files to Sell $8.4 Million in Amalgamated Stock
Carvana Co. files to sell 10 million shares of stock
Platford Giles Richard to Sell 55,617 Takeda Shares
Takeda's Teresa Bitetti to Sell 46,609 Shares Amid Tax Obligations
Kiniksa Pharmaceuticals reports significant stock sale by officer
Moat Ross to Sell Over 103,000 Shares of Kiniksa Pharmaceuticals










